Works matching IS 18696953 AND DT 2023 AND VI 14 AND IP 11


Results: 14
    1
    2
    3
    4
    5
    6
    7
    8

    Treatment with SGLT2 Inhibitors in Patients with Diabetes Mellitus and Extensive Coronary Artery Disease: Mortality and Cardiovascular Outcomes.

    Published in:
    Diabetes Therapy, 2023, v. 14, n. 11, p. 1853, doi. 10.1007/s13300-023-01454-w
    By:
    • Chipayo-Gonzales, David;
    • Shabbir, Asad;
    • Vergara-Uzcategui, Carlos;
    • Nombela-Franco, Luis;
    • Jimenez-Quevedo, Pilar;
    • Gonzalo, Nieves;
    • Nuñez-Gil, Ivan;
    • Mejia-Renteria, Hernan;
    • Macaya-Ten, Fernando;
    • Tirado-Conte, Gabriela;
    • Perez-Vizcayno, Maria Jose;
    • Fuentes, Manuel;
    • Escaned, Javier;
    • Fernandez-Ortiz, Antonio;
    • Salinas, Pablo
    Publication type:
    Article
    9

    Efficacy and Safety of a Biosimilar Liraglutide (Melitide<sup>®</sup>) Versus the Reference Liraglutide (Victoza<sup>®</sup>) in People with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Noninferiority Clinical Trial.

    Published in:
    Diabetes Therapy, 2023, v. 14, n. 11, p. 1889, doi. 10.1007/s13300-023-01462-w
    By:
    • Esteghamati, Alireza;
    • Zamanzadeh, Mehran;
    • Malek, Mojtaba;
    • Khaledi, Mohammad;
    • Monavari, Arezoo;
    • Najafi, Laily;
    • Banazadeh, Zahra;
    • Malboosbaf, Ramin;
    • Aghili, Rokhsareh;
    • Mahdikhah, Sedigheh;
    • Ganjizadeh-Zavereh, Hasan;
    • Kafi, Hamidreza;
    • Hosseinpanah, Farhad;
    • Khamseh, Mohammad Ebrahim
    Publication type:
    Article
    10
    11
    12
    13
    14